SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

18.88p
   
  • Change Today:
      0.13p
  • 52 Week High: 26.10
  • 52 Week Low: 8.50
  • Currency: UK Pounds
  • Shares Issued: 234.07m
  • Volume: 258,279
  • Market Cap: £44.18m
  • Beta: 0.03

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Executive Director: Simon Hewitson
Group Finance Director: Emily Bertram
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 18.88p
Change Today 0.13p
% Change 0.67 %
52 Week High 26.10
52 Week Low 8.50
Volume 258,279
Shares Issued 234.07m
Market Cap £44.18m
Beta 0.03

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.71% below the market average71.71% below the market average71.71% below the market average71.71% below the market average71.71% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average
Price Trend
81.14% above the market average81.14% above the market average81.14% above the market average81.14% above the market average81.14% above the market average
91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average
Income Not Available
Growth
47.65% above the market average47.65% above the market average47.65% above the market average47.65% above the market average47.65% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

SBTX Dividends

No dividends found

Trades for 29-May-2025

Time Volume / Share Price
15:58 9,439 @ 19.18p
15:52 8,294 @ 19.18p
15:01 6,000 @ 19.18p
14:45 15,000 @ 18.60p
13:02 24 @ 19.25p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page